Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability in Participants With Obesity or Overweight With Weight-Related Comorbidities [Phase 2]

View source ↗

Summary

Phase 2 study sponsored by Ascletis Pharma evaluated a drug candidate for obesity and weight-related comorbidities, assessing efficacy, safety, and tolerability…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Ascletis Pharma (China) Co., Limited | Conditions: Chronic Weight Management | Phase 2 | Status: COMPLETED